Markers of Endothelial Dysfunction: E-selectin, Endothelin-1 and von Willebrand Factor in Patients with Coronary Heart Disease, Including in Combination with Type 2 Diabetes Mellitus

被引：2
|
作者：
Zhito, Alexey, V [1 ]
Iusupova, Alfia O. [1 ]
Privalova, Elena, V [1 ]
Khabarova, Natalia, V [1 ]
Belenkov, Yurii N. [1 ]
机构：
[1] IM Sechenov First Moscow State Med Univ, Sechenov Univ, Trubetskaya Ul 8-2, Moscow 119991, Russia
来源：
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY | 2019年 / 15卷 / 06期
关键词：
ischemic heart disease; diabetes mellitus type 2; E-selectin; von Willebrand factor; endothelin-1; endothelial dysfunction; SOLUBLE E-SELECTIN; CIRCULATING ADHESION MOLECULES; ARTERY-DISEASE; INFLAMMATORY MARKERS; P-SELECTIN; GLUCOSE; ASSOCIATION; RISK; BIOMARKERS; DIAGNOSIS;
D O I：
10.20996/1819-6446-2019-15-6-892-899
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The prevalence of coronary heart disease (CHD) and type 2 diabetes mellitus (type 2 diabetes) in Russia and in the world continues to increase. Despite the prevention and optimization of therapy, CHD retains its leadership among all causes of death, and the mortality rate from type 2 diabetes and its complications gradually increases too. To improve the treatment of the above mentioned diseases, it is necessary to clarify the pathogenetic mechanisms of their development. The formation of endothelial dysfunction, characterized by an increase in the level of cell adhesion molecules and vasoconstriction, is a common link characteristic for the course and progression of CHD and type 2 diabetes. This article presents an analysis of pre-and clinical studies on the role of endothelial dysfunction markers: cell adhesion molecules (E-selectin), vasoconstriction (endothelin-1) and von Willebrand factor in patients with CHD, including those with type 2 diabetes mellitus.
引用
收藏
页码：892 / 899
页数：8
相关论文
共 50 条
  • [11] Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors
    Z Hlubocká
    V Umnerová
    S Heller
    J Peleska
    A Jindra
    M Jáchymová
    J Kvasnicka
    K Horký
    M Aschermann
    Journal of Human Hypertension, 2002, 16 : 557 - 562
  • [12] The effect of multi-factorial intervention on plasma von Willebrand factor, soluble E-selectin and tissue factor in diabetes mellitus: implications for atherosclerotic vascular disease
    Lim, HS
    Chong, AY
    Freestone, B
    Blann, AD
    Lip, GYH
    DIABETIC MEDICINE, 2005, 22 (03) : 249 - 255
  • [13] ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH OBESITY AND TYPE 2 DIABETES MELLITUS OR NORMOGLYCEMIA: ASSESSMENT OF SPECIFIC MARKERS
    Pokrovskaya, Elena V.
    Shestakova, Ekaterina A.
    V. Shestakova, Marina
    DIABETES MELLITUS, 2023, 26 (05): : 439 - 445
  • [14] Inverse relationship between plasma von Willebrand factor and soluble P selectin in patients with type 1 but not type 2 von Willebrand disease
    Blann, AD
    Nitu-Whalley, IC
    Lee, CA
    Lip, GYH
    AMERICAN JOURNAL OF HEMATOLOGY, 2002, 69 (02) : 135 - 137
  • [15] Endothelin-1 levels and albuminuria in patients with type 2 diabetes mellitus
    Zanatta, Claudete M.
    Gerchman, Fernando
    Burttet, Lucas
    Nabinger, Gustavo
    Jacques-Silva, Maria C.
    Canani, Luis H.
    Gross, Jorge L.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 80 (02) : 299 - 304
  • [16] Relations between von Willebrand factor, markers of oxidative stress and microalbuminuria in patients with type 2 diabetes mellitus
    Ibrahim, HA
    El-Meligi, AA
    Abdel-Hamid, M
    Elhendy, A
    MEDICAL SCIENCE MONITOR, 2004, 10 (03): : CR85 - CR89
  • [17] Adiposity markers and risk of coronary heart disease in patients with type 2 diabetes mellitus
    Tonding, Simone F.
    Silva, Flavia M.
    Antonio, Juliana P.
    Azevedo, Mirela J.
    Canani, Luis Henrique S.
    Almeida, Jussara C.
    NUTRITION JOURNAL, 2014, 13
  • [18] Endothelin-1 gene polymorphisms and diabetic kidney disease in patients with type 2 diabetes mellitus
    Claudete M. Zanatta
    Daisy Crispim
    Denise A. Sortica
    Lucas P. Klassmann
    Jorge L. Gross
    Fernando Gerchman
    Luís H. Canani
    Diabetology & Metabolic Syndrome, 7
  • [19] Serum von Willebrand factor for early diagnosis of lung adenocarcinoma in patients with type 2 diabetes mellitus
    Zhou, Ying-Yi
    Du, Xuan
    Tang, Jia-Li
    Wang, Qiu-Ping
    Chen, Ke
    Shi, Bi-Min
    WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (10) : 1916 - 1922
  • [20] Effect of von Wifiebrand Factor and Endothelin-1 on Formation of Thrombotic Status in Patients With Ischemic Heart Disease
    Sokolov, E. I.
    Grishina, T. I.
    Shtin, S. R.
    KARDIOLOGIYA, 2013, 53 (03) : 25 - 30
12345